Ralitza Gueorguieva
Ralitza Gueorguieva
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Move over anova: progress in analyzing repeated-measures data andits reflection in papers published in the archives of general psychiatry
R Gueorguieva, JH Krystal
Archives of general psychiatry 61 (3), 310-317, 2004
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis
DC D'Souza, E Perry, L MacDougall, Y Ammerman, T Cooper, Y Wu, ...
Neuropsychopharmacology 29 (8), 1558-1572, 2004
Subtype-specific alterations of γ-aminobutyric acid and glutamatein patients with major depression
G Sanacora, R Gueorguieva, CN Epperson, YT Wu, M Appel, ...
Archives of general psychiatry 61 (7), 705-713, 2004
Association between physical exercise and mental health in 1· 2 million individuals in the USA between 2011 and 2015: a cross-sectional study
SR Chekroud, R Gueorguieva, AB Zheutlin, M Paulus, HM Krumholz, ...
The Lancet Psychiatry 5 (9), 739-746, 2018
Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction
DC D’Souza, WM Abi-Saab, S Madonick, K Forselius-Bielen, A Doersch, ...
Biological psychiatry 57 (6), 594-608, 2005
Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations
RE Hoffman, KA Hawkins, R Gueorguieva, NN Boutros, F Rachid, ...
Archives of general psychiatry 60 (1), 49-56, 2003
Cross-trial prediction of treatment outcome in depression: a machine learning approach
AM Chekroud, RJ Zotti, Z Shehzad, R Gueorguieva, MK Johnson, ...
The Lancet Psychiatry 3 (3), 243-250, 2016
Cortical γ-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study
CN Epperson, K Haga, GF Mason, E Sellers, R Gueorguieva, W Zhang, ...
Archives of general psychiatry 59 (9), 851-858, 2002
Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function
JH Krystal, EB Perry, R Gueorguieva, A Belger, SH Madonick, ...
Archives of general psychiatry 62 (9), 985-995, 2005
Riluzole augmentation in treatment-resistant obsessive–compulsive disorder: an open-label trial
V Coric, S Taskiran, C Pittenger, S Wasylink, DH Mathalon, G Valentine, ...
Biological psychiatry 58 (5), 424-428, 2005
Cognitive–behavioral therapy, behavioral weight loss, and sequential treatment for obese patients with binge-eating disorder: A randomized controlled trial.
CM Grilo, RM Masheb, GT Wilson, R Gueorguieva, MA White
Journal of consulting and clinical psychology 79 (5), 675, 2011
Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample
RE Hoffman, R Gueorguieva, KA Hawkins, M Varanko, NN Boutros, ...
Biological psychiatry 58 (2), 97-104, 2005
Extracellular metabolites in the cortex and hippocampus of epileptic patients
I Cavus, WS Kasoff, MP Cassaday, R Jacob, R Gueorguieva, RS Sherwin, ...
Annals of neurology 57 (2), 226-235, 2005
Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II …
JH Krystal, W Abi-Saab, E Perry, DC D’Souza, N Liu, R Gueorguieva, ...
Psychopharmacology 179 (1), 303-309, 2005
Blunted psychotomimetic and amnestic effects of Δ-9-tetrahydrocannabinol in frequent users of cannabis
DC D'souza, M Ranganathan, G Braley, R Gueorguieva, Z Zimolo, ...
Neuropsychopharmacology 33 (10), 2505-2516, 2008
Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study
SW Woods, H Morgenstern, JR Saksa, BC Walsh, MC Sullivan, R Money, ...
The Journal of clinical psychiatry 71 (4), 8896, 2010
Investigating the behavioral and self-report constructs of impulsivity domains using principal component analysis
SA Meda, MC Stevens, MN Potenza, B Pittman, R Gueorguieva, ...
Behavioural pharmacology 20 (5-6), 390, 2009
Opioid Receptor Gene (OPRM1, OPRK1, and OPRD1) Variants and Response to Naltrexone Treatment for Alcohol Dependence: Results From the VA …
J Gelernter, R Gueorguieva, HR Kranzler, H Zhang, J Cramer, ...
Alcoholism: Clinical and Experimental Research 31 (4), 555-563, 2007
Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans
NR Driesen, G McCarthy, Z Bhagwagar, M Bloch, V Calhoun, DC D'Souza, ...
Molecular psychiatry 18 (11), 1199-1204, 2013
Reevaluating the efficacy and predictability of antidepressant treatments: a symptom clustering approach
AM Chekroud, R Gueorguieva, HM Krumholz, MH Trivedi, JH Krystal, ...
JAMA psychiatry 74 (4), 370-378, 2017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20